Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001731122-21-000941
Filing Date
2021-05-25
Accepted
2021-05-25 21:30:48
Documents
1
Period of Report
2021-05-21

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 31884
  Complete submission text file 0001731122-21-000941.txt   33351
Mailing Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163
Business Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163 800-689-3939
ANAVEX LIFE SCIENCES CORP. (Issuer) CIK: 0001314052 (see all company filings)

EIN.: 208365999 | State of Incorp.: NV | Fiscal Year End: 0930
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address 51 W 52ND STREET 7TH FLOOR NEW YORK NY 10091
Business Address
FAVUS ELLIOT (Reporting) CIK: 0001608022 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37606 | Film No.: 21962562